# Corebridge Financial, Inc.: financial statements, quarterly

CRBG · NYSE · CIK 1889539 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crbg.md) · [Financials](/companies/crbg/financials.md) · [Filings](/companies/crbg/filings.md) · [Insiders](/companies/crbg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crbg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,505](/filings/0001889539-24-000052.md) | [3,276 d](/filings/0001889539-26-000022.md) | [5,836](/filings/0001889539-25-000036.md) | [3,710](/filings/0001889539-25-000053.md) | [2,599](/filings/0001889539-25-000098.md) | [6,600 d](/filings/0001889539-26-000022.md) | [3,572](/filings/0001889539-26-000116.md) | [2,726](/filings/0001889539-26-000141.md) | [5,416](/filings/0001889539-25-000098.md) | [6,767 d](/filings/0001889539-26-000022.md) | [3,964](/filings/0001889539-26-000116.md) | [3,914](/filings/0001889539-26-000141.md) |
| Selling, general and administrative | $m | [611](/filings/0001889539-24-000052.md) | [485 d](/filings/0001889539-26-000022.md) | [572](/filings/0001889539-25-000036.md) | [532](/filings/0001889539-25-000053.md) | [475](/filings/0001889539-25-000098.md) | [475 d](/filings/0001889539-26-000022.md) | [526](/filings/0001889539-26-000116.md) | [517](/filings/0001889539-26-000141.md) | [481](/filings/0001889539-25-000098.md) | [478 d](/filings/0001889539-26-000022.md) | [468](/filings/0001889539-26-000116.md) | [466](/filings/0001889539-26-000141.md) |
| Interest expense | $m | [135](/filings/0001889539-24-000052.md) | [139 d](/filings/0001889539-26-000022.md) | [138](/filings/0001889539-25-000036.md) | [138](/filings/0001889539-25-000053.md) | [133](/filings/0001889539-25-000098.md) | [145 d](/filings/0001889539-26-000022.md) | [148](/filings/0001889539-26-000116.md) | [137](/filings/0001889539-26-000141.md) | [135](/filings/0001889539-25-000098.md) | [132 d](/filings/0001889539-26-000022.md) | [131](/filings/0001889539-26-000116.md) | [131](/filings/0001889539-26-000141.md) |
| Income tax | $m | [392](/filings/0001889539-24-000052.md) | [(432) d](/filings/0001889539-26-000022.md) | [189](/filings/0001889539-25-000036.md) | [115](/filings/0001889539-25-000053.md) | [(407)](/filings/0001889539-25-000098.md) | [703 d](/filings/0001889539-26-000022.md) | [(205)](/filings/0001889539-26-000116.md) | [60.0](/filings/0001889539-26-000141.md) | [(179)](/filings/0001889539-25-000098.md) | [173 d](/filings/0001889539-26-000022.md) | [158](/filings/0001889539-26-000116.md) | [50.0](/filings/0001889539-26-000141.md) |
| Net income | $m | [2,101](/filings/0001889539-24-000052.md) | [(1,309) d](/filings/0001889539-26-000022.md) | [878](/filings/0001889539-25-000036.md) | [365](/filings/0001889539-25-000053.md) | [(1,184)](/filings/0001889539-25-000098.md) | [2,171 d](/filings/0001889539-26-000022.md) | [(664)](/filings/0001889539-26-000116.md) | [(660)](/filings/0001889539-26-000141.md) | [144](/filings/0001889539-25-000098.md) | [814 d](/filings/0001889539-26-000022.md) | [(53.0)](/filings/0001889539-26-000116.md) | [2.0](/filings/0001889539-26-000141.md) |
| Diluted EPS | $ per share | [3.28](/filings/0001889539-24-000052.md) | not reported | [1.41](/filings/0001889539-25-000036.md) | [0.59](/filings/0001889539-25-000053.md) | [(2.02)](/filings/0001889539-25-000098.md) | not reported | [(1.19)](/filings/0001889539-26-000116.md) | [(1.20)](/filings/0001889539-26-000141.md) | [0.27](/filings/0001889539-25-000098.md) | not reported | [(0.11)](/filings/0001889539-26-000116.md) | [(0.04)](/filings/0001889539-26-000141.md) |
| Basic EPS | $ per share | [3.29](/filings/0001889539-24-000052.md) | not reported | [1.41](/filings/0001889539-25-000036.md) | [0.60](/filings/0001889539-25-000053.md) | [(2.02)](/filings/0001889539-25-000098.md) | not reported | [(1.19)](/filings/0001889539-26-000116.md) | [(1.20)](/filings/0001889539-26-000141.md) | [0.27](/filings/0001889539-25-000098.md) | not reported | [(0.11)](/filings/0001889539-26-000116.md) | [(0.04)](/filings/0001889539-26-000141.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001889539-24-000052.md) | [0.6](/filings/0001889539-26-000022.md) | [0.4](/filings/0001889539-25-000036.md) | [0.6](/filings/0001889539-25-000053.md) | [0.5](/filings/0001889539-25-000098.md) | [0.8](/filings/0001889539-26-000022.md) | [0.4](/filings/0001889539-26-000116.md) | [0.3](/filings/0001889539-26-000141.md) | [0.3](/filings/0001889539-25-000098.md) | [0.4](/filings/0001889539-26-000141.md) | [0.4](/filings/0001889539-26-000116.md) | [0.4](/filings/0001889539-26-000141.md) |
| Total assets | $bn | [356](/filings/0001889539-23-000027.md) | [379](/filings/0001889539-25-000014.md) | [386](/filings/0001889539-24-000022.md) | [382](/filings/0001889539-24-000030.md) | [399](/filings/0001889539-24-000052.md) | [389](/filings/0001889539-26-000022.md) | [390](/filings/0001889539-25-000036.md) | [399](/filings/0001889539-25-000053.md) | [411](/filings/0001889539-25-000098.md) | [414](/filings/0001889539-26-000141.md) | [407](/filings/0001889539-26-000116.md) | [416](/filings/0001889539-26-000141.md) |
| Total liabilities | $bn | [346](/filings/0001889539-23-000027.md) | [367](/filings/0001889539-25-000014.md) | [373](/filings/0001889539-24-000022.md) | [371](/filings/0001889539-24-000030.md) | [385](/filings/0001889539-24-000052.md) | [377](/filings/0001889539-26-000022.md) | [377](/filings/0001889539-25-000036.md) | [386](/filings/0001889539-25-000053.md) | [397](/filings/0001889539-25-000098.md) | [400](/filings/0001889539-26-000141.md) | [396](/filings/0001889539-26-000116.md) | [404](/filings/0001889539-26-000141.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [1.0](/filings/0001889539-23-000027.md) | [0.3](/filings/0001889539-25-000014.md) | [0.3](/filings/0001889539-24-000022.md) | [0.3](/filings/0001889539-24-000030.md) | [0.0](/filings/0001889539-24-000052.md) | [1.1](/filings/0001889539-26-000022.md) | [1.1](/filings/0001889539-25-000036.md) | [0.1](/filings/0001889539-25-000053.md) | [0.0](/filings/0001889539-25-000098.md) | [0.0](/filings/0001889539-26-000141.md) | not reported | [1.3](/filings/0001889539-26-000141.md) |
| Shareholders' equity | $bn | [8.4](/filings/0001889539-23-000027.md) | [11.8](/filings/0001889539-25-000014.md) | [11.6](/filings/0001889539-24-000022.md) | [11.0](/filings/0001889539-24-000030.md) | [13.6](/filings/0001889539-24-000052.md) | [11.5](/filings/0001889539-26-000022.md) | [12.0](/filings/0001889539-25-000036.md) | [12.3](/filings/0001889539-25-000053.md) | [13.5](/filings/0001889539-25-000098.md) | [13.2](/filings/0001889539-26-000141.md) | [10.8](/filings/0001889539-26-000116.md) | [10.7](/filings/0001889539-26-000141.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,018 d](/filings/0001889539-24-000052.md) | [767 d](/filings/0001889539-26-000022.md) | [598](/filings/0001889539-25-000036.md) | [(9.0) d](/filings/0001889539-25-000053.md) | [83.0 d](/filings/0001889539-25-000098.md) | [1,479 d](/filings/0001889539-26-000022.md) | [375](/filings/0001889539-26-000116.md) | [(259) d](/filings/0001889539-26-000141.md) | [24.0 d](/filings/0001889539-25-000098.md) | [1,881 d](/filings/0001889539-26-000022.md) | [(9.0)](/filings/0001889539-26-000116.md) | [(44.0) d](/filings/0001889539-26-000141.md) |
| Dividends paid | $m | [146 d](/filings/0001889539-24-000052.md) | [876 d](/filings/0001889539-26-000022.md) | [143](/filings/0001889539-25-000036.md) | [139 d](/filings/0001889539-25-000053.md) | [133 d](/filings/0001889539-25-000098.md) | [129 d](/filings/0001889539-26-000022.md) | [133](/filings/0001889539-26-000116.md) | [131 d](/filings/0001889539-26-000141.md) | [128 d](/filings/0001889539-25-000098.md) | [119 d](/filings/0001889539-26-000022.md) | [114](/filings/0001889539-26-000116.md) | [112 d](/filings/0001889539-26-000141.md) |
| Share repurchases | $m | [46.0 d](/filings/0001889539-24-000052.md) | [252 d](/filings/0001889539-26-000022.md) | [243](/filings/0001889539-25-000036.md) | [436 d](/filings/0001889539-25-000053.md) | [715 d](/filings/0001889539-25-000098.md) | [398 d](/filings/0001889539-26-000022.md) | [321](/filings/0001889539-26-000116.md) | [311 d](/filings/0001889539-26-000141.md) | [380 d](/filings/0001889539-25-000098.md) | [1,106 d](/filings/0001889539-26-000022.md) | [1,250](/filings/0001889539-26-000116.md) | [300 d](/filings/0001889539-26-000141.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [646](/filings/0001889539-23-000027.md) | [651](/filings/0001889539-24-000022.md) | [652](/filings/0001889539-24-000030.md) | [641](/filings/0001889539-24-000052.md) | [625](/filings/0001889539-25-000036.md) | [613](/filings/0001889539-25-000053.md) | [587](/filings/0001889539-25-000098.md) | [558](/filings/0001889539-26-000116.md) | [550](/filings/0001889539-26-000141.md) | [541](/filings/0001889539-25-000098.md) | [474](/filings/0001889539-26-000116.md) | [454](/filings/0001889539-26-000141.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 445,772,522 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001889539-26-000141.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.